Ayuda
Ir al contenido

Dialnet


Menopausal Hormone Therapy: Current Considerations

  • Autores: Cynthia A. Stuenkel
  • Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 44, Nº. 3, 2015 (Ejemplar dedicado a: Postmenopausal Endocrinology), págs. 565-585
  • Idioma: inglés
  • Texto completo no disponible (Saber más ...)
  • Resumen
    • Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor and vaginal symptoms. Today, symptomatic women younger than 60 years of age or less than 10 years since onset of menopause yield the greatest benefit of MHT with the lowest risks when compared with older women remote from menopause. Careful assessment before initiating therapy includes severity of bothersome symptoms, treatment preferences, medical history, presence of contraindications to MHT, and personal risk of cardiovascular disease and breast cancer. Considerations of type of MHT, dosing, and route of administration, and recommendations regarding duration of therapy are discussed.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno